CEO of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev on Monday confirmed that the clinical trial of the SPUTNIK V vaccine will begin in different countries including India.
There are 20 countries, including the UAE, Saudi Arabia, Indonesia, Philippines, Mexico, Brazil and India that have expressed their interest in obtaining the vaccine.
Dmitriev told CNBT TV18 that if all goes well, Russia could start delivering COVID-19 vaccine from November this year, with some 30 crore doses produced in India.
The coronavirus cases in India is so far at around 4.28 million cases and 3.32 Million of recovered cases and the death of 72,775 people has been confirmed, and the new cases still being recorded in large numbers throughout India.
Head of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev stated,
Russia is in close talks with the Indian Government and the drug manufactures in India including serum institute about the production of SPUTNIK V vaccines in India.
“We do recognize India’s potential to become a support for the production of the vaccine not only in Indian markets but for other countries too, and we have achieved certain agreements with the leading companies,” he informed.
“As far as Sputnik V vaccine is concerned, both India and Russia are in communication,” Union Health Secretary Rajesh Bhushan said at a press conference held in late August. “Some initial information has been shared while some detailed information is awaited.”
Russian Defense Minister Sergei Shoigu said in a television interview with Rossiya 1 ,”I feel quite all right. I have neither run a high temperature nor experienced any other side effects. I advise everyone to undergo vaccination,”